• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Everything Is Obvious

25/03/2019 by Intellectual Property Watch 4 Comments

Ryan Abbott writes: For more than sixty years, “obviousness” has set the bar for patentability.  Under this standard, if a hypothetical “person having ordinary skill in the art” would find an invention obvious in light of existing relevant information, then the invention cannot be patented.  This skilled person is defined as a non-innovative worker with a limited knowledge-base.  The more creative and informed the skilled person, the more likely an invention will be considered obvious.  The standard has evolved since its introduction, and it is now on the verge of an evolutionary leap: Inventive machines are increasingly being used in research, and once the use of such machines becomes standard, the person skilled in the art should be a person using an inventive machine, or just an inventive machine.  Unlike the skilled person, the inventive machine is capable of innovation and considering the entire universe of prior art.  As inventive machines continue to improve, this will increasingly raise the bar to patentability, eventually rendering innovative activities obvious.  The end of obviousness means the end of patents, at least as they are now.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, English, Human Rights, Innovation/ R&D, New Technologies, North America, Patents/Designs/Trade Secrets, Regional Policy

Saudis Seek Alternative Energy Partners Through WIPO Green Program

20/03/2019 by Intellectual Property Watch Leave a Comment

The government of oil-dependent Saudi Arabia has posted a series of requests for proposals for renewable energy technology partnerships via the World Intellectual Property Organization “Green” initiative that provides a marketplace for IP-protected products related to the environment.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Asia/Pacific, English, Environment, Human Rights, Patents/Designs/Trade Secrets, Regional Policy, WIPO

Will US Drug Pricing Politics Change Intimidation Practices Globally?

05/03/2019 by Intellectual Property Watch 2 Comments

Fifa Rahman

Fifa Rahman writes: The global health world, particularly as concerns skyrocketing drug prices and patent abuse, is in a unique space in time. Recently, the Office of the United States Trade Representative (USTR) has been carrying on as per usual. It has threatened the Malaysian and Colombian governments at numerous junctures to prevent them from issuing compulsory licences – a completely legal mechanism which the US uses regularly – to access generic hepatitis C drugs. The Trump Administration has sent delegations to global health agencies in Geneva to intimidate them into reducing, or hiding, work on TRIPS flexibilities and fairer drug pricing.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Asia/Pacific, Bilateral/Regional Negotiations, English, Health & IP, Human Rights, North America, Patents/Designs/Trade Secrets, Regional Policy, WTO/TRIPS

Rise Of The Machines: Experts Look At AI, Robotics And The Law

27/02/2019 by William New, Intellectual Property Watch 2 Comments

NEW YORK — Artificial intelligence, robots, and the law, are all changing a rapid pace. A panel of experts at a recent event at Fordham Law School discussed latest developments and signs of the limits of the law when applied to AI areas like facial recognition, automated weapons systems, and financial technology.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Human Rights, IP Law, Innovation/ R&D, New Technologies, North America, Patents/Designs/Trade Secrets, Regional Policy

Asian NGOs Raise Concern Over IP And Seeds In RCEP Trade Deal

26/02/2019 by William New, Intellectual Property Watch 1 Comment

The Regional Comprehensive Economic Partnership (RCEP) trade agreement under negotiation among Asia and Pacific nations must not include measures that would undercut countries’ ability to protect diverse local farming systems and sustainable plant genetic resources for food and agriculture, a range of Asian nongovernmental organisations argue. Groups in India, Malaysia and the Philippines this week specifically called for the RCEP not to include the high-level protections under the International Union for the Protection of New Varieties of Plants (UPOV).

Filed Under: IP Policies, Themes, Venues, Bilateral/Regional Negotiations, Biodiversity/Genetic Resources/Biotech, English, Environment, Human Rights, Lobbying, Patents/Designs/Trade Secrets, Traditional and Indigenous Knowledge, UPOV / CBD

Malaysia Still Under Pressure To Make Hepatitis C Medicine More Expensive

13/02/2019 by William New, Intellectual Property Watch Leave a Comment

The government of Malaysia continues to face pressure from the United States pharmaceutical industry and potentially the US government to undo an action taken to make a key hepatitis C medicine more affordable in the country. Now Médecins Sans Frontières (MSF, Doctors Without Borders) has weighed in to defend the government’s right to use a patent flexibility in global trade law that allows them to take such actions on behalf of their citizens.

Filed Under: IP Policies, Themes, Venues, Asia/Pacific, English, Health & IP, Human Rights, Lobbying, Patents/Designs/Trade Secrets, Regional Policy, WTO/TRIPS

Switzerland Receives Request For Compulsory Licence On Breast Cancer Drug

01/02/2019 by Intellectual Property Watch 1 Comment

Swiss health activist group Public Eye yesterday requested the Swiss government to declare a compulsory licence for a Roche breast cancer treatment which the group says is unaffordable.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Europe, Health & IP, Human Rights, Lobbying, Patents/Designs/Trade Secrets, Regional Policy

WHO’s Access Roadmap And The Art Of Accommodation Of Pharma Interest

26/01/2019 by Intellectual Property Watch 1 Comment

The Roadmap to access to medicines, vaccines and other health products (Roadmap) to be discussed at this week’s 144th session of WHO’s Executive Board accommodates vital interest of pharmaceutical TNCs on critical issues such as the approach to access, technical assistance on the use of TRIPS flexibilities and access to biosimilars.

Adoption of the Roadmap in its current form very well accommodates the interest of the Pharmaceutical TNCs and therefore one need not expect any proactive steps by WHO towards promoting access after the adoption of the Roadmap.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, English, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO, WIPO, WTO/TRIPS

WHO Cancer Report Stirs Debate On Eve Of Board Meeting

23/01/2019 by William New, Intellectual Property Watch 3 Comments

As the World Health Organization Executive Board gathers tomorrow for its annual January meeting, health industry and advocacy groups have seized on a WHO report to be presented to the Board that finds high prices for cancer medicines are “impairing” governments’ ability to provide affordable treatments. One issue they may have in common is a desire for more transparency in analyses of prices.

Filed Under: IP Policies, Themes, Venues, English, Health & IP, Human Rights, Lobbying, Patents/Designs/Trade Secrets, WHO

WHO Report Shows Global Progress On Influenza Preparedness Response

18/12/2018 by David Branigan, Intellectual Property Watch Leave a Comment

The World Health Organization has released a new report showing that significant progress has been made to build national and global preparedness for future influenza pandemics. This progress resulted from the collaborative multi-sectoral implementation of a WHO plan, funded by the benefit-sharing contributions of industry partners, to strengthen global health security against pandemic influenza.

Filed Under: IP Policies, Language, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Finance, Health & IP, Human Rights, Patents/Designs/Trade Secrets, WHO

  • 1
  • 2
  • 3
  • …
  • 156
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2022 · Global Policy Reporting